Follow Us:
Piroxicam

Suganril

Piroxicam

Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of pain and inflammation associated with rheumatoid arthritis, osteoarthritis, and other musculoskeletal disorders. It belongs to the oxicam derivative class of NSAIDs. It works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing prostaglandin production and relieving pain, inflammation, and swelling. Piroxicam is available in oral capsules, tablets, and topical gel formulations. Common side effects include nausea, abdominal pain, indigestion, and dizziness. Serious adverse effects may include gastrointestinal bleeding, kidney damage, and cardiovascular complications. It should be used under medical supervision, particularly in patients with stomach ulcers, kidney disease, or heart conditions.

Dosage Form: Tablet
Dosage Strength:
CAS No.: 36322-90-4
Status:
Manufacturer:
Group: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Sub Group: Non-selective COX inhibitors
Class: Oxicam derivatives

Uses of Piroxicam

Piroxicam was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

  • Rheumatoid arthritis: Relief of joint pain, swelling, and inflammation.
  • Osteoarthritis: Management of pain and stiffness associated with degenerative joint disease.
  • Ankylosing spondylitis: Reduction of inflammatory spinal pain and stiffness with selected medicines.
  • Musculoskeletal disorders: Treatment of back pain, sprains, strains, and other painful musculoskeletal conditions.
  • Acute gout: Certain oxicams may be used to manage pain and inflammation during acute gout attacks, depending on local prescribing guidance.
  • Postoperative pain: Selected formulations, such as injectable lornoxicam, may be used for short-term postoperative pain management.
  • Acute inflammatory pain: Relief of pain and inflammation associated with selected joint and soft-tissue conditions.

Contraindication of Piroxicam

Piroxicam was historically subject to specific precautions during administration to ensure patient safety. Its former precautions included:

  • Known hypersensitivity to the medicine, aspirin, or other NSAIDs.
  • Previous serious allergic reactions, including NSAID-induced asthma, urticaria, or angioedema.
  • Active peptic ulcer disease or gastrointestinal bleeding.
  • History of serious NSAID-related gastrointestinal bleeding or perforation.
  • Severe renal impairment or severe hepatic impairment.
  • Severe heart failure or certain serious cardiovascular conditions.
  • Active pathological bleeding or significant bleeding disorders.
  • Perioperative pain management associated with coronary artery bypass graft (CABG) surgery.
  • Late pregnancy, particularly from 30 weeks onward.

Precautions for Piroxicam

Piroxicam was majorly subjected to specific precautions during administration to ensure patient safety. Its former precautions included:

  • Gastrointestinal complications: Oxicams may cause stomach irritation, peptic ulcers, gastrointestinal bleeding, and, rarely, perforation. Piroxicam is associated with a relatively high gastrointestinal risk compared with several other NSAIDs.
  • Cardiovascular risk: Use cautiously in patients with hypertension, ischaemic heart disease, previous stroke, or heart failure because NSAIDs may increase cardiovascular complications and fluid retention.
  • Kidney impairment: Oxicams may reduce renal blood flow and cause kidney injury, particularly in patients with dehydration or pre-existing kidney disease.
  • Liver function: Liver enzyme elevations and, rarely, hepatic injury may occur. Monitoring may be necessary during prolonged treatment.
  • Skin reactions: Serious skin reactions, including Stevens–Johnson syndrome and toxic epidermal necrolysis, have been reported, particularly with piroxicam. Patients should seek immediate medical attention for severe rash or blistering.
  • Asthma and allergies: Patients with aspirin-sensitive asthma or previous NSAID-related allergic reactions should avoid these medicines unless specifically advised by a healthcare professional.
  • Pregnancy: Avoid routine use from 20 weeks of pregnancy unless specifically advised by a healthcare professional. Use from 30 weeks onward is generally avoided.
  • Elderly patients: Older adults may have an increased risk of gastrointestinal bleeding, kidney complications, and cardiovascular adverse effects.
  • Treatment duration: Use the lowest effective dose for the shortest appropriate period.

Drug Interactions for Piroxicam

Potential drug interactions were historically documented when Piroxicam was prescribed alongside certain medications. These included:

  • Anticoagulants: Warfarin and direct oral anticoagulants may increase the risk of gastrointestinal and other bleeding.
  • Antiplatelet medicines: Aspirin and clopidogrel may increase bleeding risk when combined with oxicams.
  • Corticosteroids: Prednisolone and other corticosteroids may increase the risk of gastrointestinal ulcers and bleeding.
  • ACE inhibitors and ARBs: Concurrent use may reduce blood-pressure control and increase the risk of kidney injury.
  • Diuretics: Oxicams may reduce diuretic effectiveness and increase the risk of fluid retention and renal impairment.
  • Lithium: Oxicams may increase lithium concentrations and the risk of toxicity.
  • Methotrexate: Concurrent use may reduce methotrexate clearance and increase the risk of toxicity.
  • Cyclosporine and tacrolimus: Combination may increase the risk of kidney damage.
  • Other NSAIDs: Combining oxicams with other NSAIDs may increase gastrointestinal, renal, and cardiovascular adverse effects.

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Piroxicam.

The Piroxicam is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Piroxicam.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Piroxicam, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Piroxicam Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Piroxicam

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Piroxicam Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Piroxicam, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Piroxicam

The export of Piroxicam from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Piroxicam Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Piroxicam specifications, certificates of analysis, and other supporting documents required for Piroxicam export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Piroxicam export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Piroxicam regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Piroxicam documentation, labelling, Piroxicam manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Piroxicam Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Piroxicam, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.